CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-24 | Poulton Jeffrey V. EVP, Chief Financial Officer | Grant or award | +3,278 | 30,497 | ||
| 2024-06-24 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award | +3,278 | 13,265 | ||
| 2024-06-24 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Grant or award | +2,498 | 15,379 | ||
| 2024-05-29 | SCHULMAN AMY W Director | Exercise or conversion 10b5-1 | +30,000 | $66.83 | $2.0M | 30,136 |
| 2024-05-29 | SCHULMAN AMY W Director | Sale 10b5-1 | −10,121 | $148.21 | $1.5M | 20,015 |
| 2024-05-29 | SCHULMAN AMY W Director | Sale 10b5-1 | −11,516 | $148.93 | $1.7M | 8,499 |
| 2024-05-29 | SCHULMAN AMY W Director | Sale 10b5-1 | −63 | $149.76 | $9K | 8,436 |
| 2024-05-29 | SCHULMAN AMY W Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −30,000 | 0 | ||
| 2024-05-16 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | KELLOGG PETER N Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | Bertozzi Carolyn R Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | Sigal Charles Elliott Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | BRANDICOURT OLIVIER Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | HAMBURG MARGARET A Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | Reitan Colleen F Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | BONNEY MICHAEL W Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | SCHULMAN AMY W Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-05-16 | SHARP PHILLIP A Director | Grant or award · Stock Option (right to buy) | +5,228 | 5,228 | ||
| 2024-03-01 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award | +4,751 | 9,987 |
Page 47 of 80 · 1,590 trades